| Typicality: | 0.512 |
| Saliency: | 0.348 |
| in cancer patients | 8 | location |
| mostly | 3 | degree |
| in the postpartum period | 2 | temporal |
| drug → treat → anemia | 17 |
| drug → be used to treat → anemia | 13 |
| drug → reduce → anemia | 5 |
| drug → be designed to treat → anemia | 3 |
| drug → be prescribed for → anemia | 3 |
| negative | neutral | positive |
| 0.251 | 0.618 | 0.132 |
| Raw frequency | 41 |
| Normalized frequency | 0.348 |
| Modifier score | 0.850 |
| Perplexity | 36.915 |